Collagen and Elastin Synthesis GHK-Cu activates dermal fibroblasts to increase production of type I and type III collagen and elastin
Injectable Protocol (Systemic + Gut) For users who want systemic delivery alongside gut-targeted action: Loading Phase (Weeks 1 to 4): BPC-157: 250 to 500 mcg per day, subcutaneous injection (abdomen) KPV: 200 to 500 mcg per day, subcutaneous injection (abdomen) Maintenance Phase (Weeks 5 to 8): BPC-157: 250 mcg per day KPV: 200 to 300 mcg per day Extended Stack Options For enhanced regenerative effect beyond gut health, some practitioners add: TB-500: 2 to 2.5 mg twice weekly adds systemic cell migration and tissue remodeling for broader recovery GHK-Cu: 1 to 2 mg per day subcutaneous adds collagen production support and wound healing acceleration Timing and Administration Notes For oral gut-focused use, some users dose BPC-157 in the morning and KPV in the evening to maintain continuous coverage throughout the day
All glucocorticoids are Prohibited during the In-Competition period when administered by any injectable, oral [including oromucosal (e.g
If joint pain is persistent, it's worth seeing a healthcare professional to rule out inflammatory arthritis
Metabolic factors influencing menstrual function during weight loss: Leptin levels: This adipocyte-derived hormone decreases with fat loss and plays a crucial role in reproductive function signaling Insulin sensitivity: Improved insulin sensitivity can normalize androgen levels, particularly beneficial in PCOS Inflammatory markers: Reduction in chronic low-grade inflammation associated with obesity Sex hormone-binding globulin (SHBG): Levels typically increase with weight loss, affecting free hormone availability For women with obesity-related reproductive dysfunction, particularly those with PCOS, moderate and sustained weight loss often improves menstrual regularity over time
(1) Studies on the Validation of In Vivo Obesity Intervention Effects A large number of in vivo animal experiments have confirmed that it exerts significant weightloss and fatreducing effects with favorable safety profiles.In a mouse model of highfat dietinduced obesity, administration of 20 mg/kg NNMTi daily for 11 days resulted in a significant reduction in body weight
